<div id="readability-page-1">11:11 AM EST, 02/20/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts edged up 0.1% to 1,845.20 on the S&amp;P Europe Select ADR Index late Friday morning. It was up 1.76% for the week.From continental Europe, the gainers were led by semiconductor firm Sequans Communications ( SQNS ) and biopharmaceutical company DBV Technologies ( DBVT ) , which rose 2.4% and 2% respectively. They were followed by lender ING (ING) and software firm SAP (SAP), which rose 1.7% and 1.5% respectively.The decliners from continental Europe were led by Ascendis Pharma ( ASND ) and 3D printer company Materialise (MTLS), which fell 2.8% and 2.5% respectively. They were followed by pharmaceutical firm Novo Nordisk ( NVO ) , which was down 2.4%.From the UK and Ireland, the gainers were led by alcoholic beverage company Diageo ( DEO ) and Endava ( DAVA ) , which advanced 3.6% and 3.4% respectively. They were followed by biopharmaceutical companies Akari Therapeutics ( AKTX ) and NuCana ( NCNA ) , which were up 3.1% and 2.1% respectively.The decliners from the UK and Ireland were led by Biodexa Pharmaceuticals ( BDRX ) and Trinity Biotech ( TRIB ) , which dropped 7% and 3.1% respectively. They were followed by Bicycle Therapeutics ( BCYC ) , which lost 2%. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

Sequans通信

DAVA

帝亚吉欧

DBV 科技

欧洲股指基金投资组合 ETF - SPDR

Trinity生物科技-A

BDRX

Ascendis制药

MTLS

在美国交易的欧洲股票略有上涨，标准普尔欧洲精选 ADR 指数上涨 0.1%，达到 1,845.20，周涨幅为 1.76%。值得注意的涨幅股票包括 Sequans Communications 和 DBV Technologies，而 Ascendis Pharma 和 Materialise 则在下跌之列。在英国和爱尔兰，帝亚吉欧和 Endava 领涨，而 Biodexa Pharmaceuticals 和 Trinity Biotech 则经历了显著下跌。MT Newswires 不提供投资建议

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday trading

fidelity

Endava

Biodexa Pharmaceuticals

Materialise

在美国以美国存托凭证形式交易的欧洲股票在周五的交易中小幅上涨